PL355607A1 - Ulepszony sposób otrzymywania aminotetralin podstawionych azotem - Google Patents

Ulepszony sposób otrzymywania aminotetralin podstawionych azotem

Info

Publication number: PL355607A1
Authority: PL; Poland
Prior art keywords: improved process; preparing nitrogen; substituted aminotetralins; aminotetralins; substituted
Prior art date: 1999-11-23

Application number

PL00355607A

Other languages

English (en)

Other versions

PL202805B1 (pl

Inventor

Gevork Minaskanian

Keith Rippel

Original Assignee

Aderis Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-23

Filing date

2000-11-16

Publication date

2004-05-04

2000-11-16 Application filed by Aderis Pharmaceuticals, Inc. filed Critical Aderis Pharmaceuticals, Inc.

2004-05-04 Publication of PL355607A1 publication Critical patent/PL355607A1/pl

2009-07-31 Publication of PL202805B1 publication Critical patent/PL202805B1/pl

Links

238000004519 manufacturing process Methods 0.000 title 1
-1 nitrogen-substituted aminotetralins Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)

PL355607A 1999-11-23 2000-11-16 Sposób otrzymywania aminotetralin podstawionych azotem PL202805B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16700999P	1999-11-23	1999-11-23
PCT/US2000/031415 WO2001038321A1 (en)	1999-11-23	2000-11-16	Improved process for preparing nitrogen-substituted aminotetralins

Publications (2)

Publication Number	Publication Date
PL355607A1 true PL355607A1 (pl)	2004-05-04
PL202805B1 PL202805B1 (pl)	2009-07-31

Family

ID=22605581

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL355607A PL202805B1 (pl)	1999-11-23	2000-11-16	Sposób otrzymywania aminotetralin podstawionych azotem

Country Status (15)

Country	Link
US (1)	US6372920B1 (pl)
EP (1)	EP1232152B1 (pl)
CN (1)	CN1185225C (pl)
AR (1)	AR026505A1 (pl)
AT (1)	ATE258927T1 (pl)
AU (1)	AU1613101A (pl)
CA (1)	CA2392563C (pl)
DE (1)	DE60008136T2 (pl)
DK (1)	DK1232152T3 (pl)
ES (1)	ES2216992T3 (pl)
HK (2)	HK1049156B (pl)
PL (1)	PL202805B1 (pl)
PT (1)	PT1232152E (pl)
TR (1)	TR200400401T4 (pl)
WO (1)	WO2001038321A1 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19814084B4 (de) *	1998-03-30	2005-12-22	Lts Lohmann Therapie-Systeme Ag	D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) *	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
US20030027793A1 (en) *	2001-05-08	2003-02-06	Thomas Lauterback	Transdermal treatment of parkinson's disease
US20030026830A1 (en) *	2001-05-08	2003-02-06	Thomas Lauterback	Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US8246980B2 (en) *	2002-07-30	2012-08-21	Ucb Pharma Gmbh	Transdermal delivery system
DE10234673B4 (de) *	2002-07-30	2007-08-16	Schwarz Pharma Ag	Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8211462B2 (en) *	2002-07-30	2012-07-03	Ucb Pharma Gmbh	Hot-melt TTS for administering rotigotine
US8246979B2 (en) *	2002-07-30	2012-08-21	Ucb Pharma Gmbh	Transdermal delivery system for the administration of rotigotine
DE10261696A1 (de)	2002-12-30	2004-07-15	Schwarz Pharma Ag	Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) *	2003-07-26	2007-07-05	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung von Depressionen
DE10359528A1 (de) *	2003-12-18	2005-07-28	Schwarz Pharma Ag	(S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) *	2003-12-24	2005-07-28	Schwarz Pharma Ag	Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) *	2004-02-20	2005-09-08	Schwarz Pharma Ag	Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) *	2004-03-24	2006-07-06	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
TWI392670B (zh) *	2006-06-22	2013-04-11	Ucb Pharma Gmbh	經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
EP1987815A1 (en) *	2007-05-04	2008-11-05	Schwarz Pharma Ag	Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
WO2008146284A2 (en) *	2007-05-30	2008-12-04	Chemagis Ltd.	Crystalline rotigotine base and preparation process therefor
WO2009053697A1 (en) *	2007-10-26	2009-04-30	Pliva Hrvatska D.O.O.	Polymorphic forms of ( s ) -rotigotine hydrochloride
WO2009056791A1 (en) *	2007-11-02	2009-05-07	Pliva Hrvatska D.O.O.	Processes for preparing pharmaceutical compounds
EA017836B1 (ru)	2007-11-28	2013-03-29	ЮСиБи ФАРМА ГМБХ	Новая полиморфная форма ротиготина и способ ее получения
US20090202647A1 (en) *	2008-02-11	2009-08-13	Mayur Devjibhai Khunt	Solid form of racemic rotigotine
IT1392387B1 (it) *	2008-09-26	2012-03-02	Solmag S P A Ora Fidia Farmaceutici S P A	Processo per la preparazione di rotigotina
EP2376470B1 (en) *	2008-12-09	2013-04-10	Interquim, S.A	Process for the preparation of (6s)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (rotigotine)
WO2010073124A2 (en)	2008-12-26	2010-07-01	Actavis Group Ptc Ehf	Processes for preparing highly pure rotigotine or a pharmaceutically acceptable salt thereof
EP2281559A1 (en)	2009-06-26	2011-02-09	UCB Pharma GmbH	Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
CN102010400B (zh)	2009-09-07	2015-02-04	药源药物化学（上海）有限公司	S-5-取代-n-2'-(噻吩-2-基-)乙基-1,2,3,4-四氢萘-2-胺或其手性酸盐和用于制备罗替戈汀
EP2490673A2 (en)	2009-10-19	2012-08-29	Actavis Group Ptc Ehf	Amorphous rotigotine co-precipitates
DE102009052972A1 (de)	2009-11-12	2011-09-15	Lts Lohmann Therapie-Systeme Ag	Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
CN104189912A (zh)	2009-12-22	2014-12-10	优时比制药有限公司	用于使非结晶形式的罗替戈汀的固体分散体稳定化的聚乙烯吡咯烷酮
IN2012DN06562A (pl)	2010-02-05	2015-10-23	Ucb Pharma Gmbh
JP5748848B2 (ja)	2010-06-25	2015-07-15	ウーツェーベーファルマゲーエムベーハーＵｃｂＰｈａｒｍａＧｍｂｈ	窒素置換（ｓ）−５−アルコキシ−２−アミノテトラリン誘導体の分割方法
KR101478597B1 (ko)	2011-06-27	2015-01-02	산동 루예 파마슈티칼 컴파니 리미티드	질소 치환 아미노-5,6,7,8-테트라하이드로나프톨의 공업화 제조방법
CN103768043B (zh) *	2012-10-22	2015-12-09	苏州药明康德新药开发股份有限公司	采用羟丙基-β-环糊精配制四氢化萘类化合物均一稳定溶液的方法
US10611749B2 (en)	2018-02-15	2020-04-07	Solara Active Pharma Sciences Limited	Process for preparation of Rotigotine and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3062971D1 (en)	1979-09-14	1983-06-09	Sandoz Ag	Derivatives of tetraline, their preparation and medicaments containing these compounds
US4564628A (en)	1983-01-03	1986-01-14	Nelson Research & Development Co.	Substituted 2-aminotetralins
US4968837A (en)	1989-07-28	1990-11-06	Ethyl Corporation	Resolution of racemic mixtures
US5382596A (en) *	1993-08-05	1995-01-17	Whitby Research, Inc.	Substituted 2-aminotetralins

2000
- 2000-11-16 AR ARP000106056A patent/AR026505A1/es not_active Application Discontinuation
- 2000-11-16 PT PT00978699T patent/PT1232152E/pt unknown
- 2000-11-16 DK DK00978699T patent/DK1232152T3/da active
- 2000-11-16 HK HK03100524.2A patent/HK1049156B/en not_active IP Right Cessation
- 2000-11-16 TR TR2004/00401T patent/TR200400401T4/xx unknown
- 2000-11-16 AU AU16131/01A patent/AU1613101A/en not_active Abandoned
- 2000-11-16 CA CA2392563A patent/CA2392563C/en not_active Expired - Lifetime
- 2000-11-16 HK HK03104901.7A patent/HK1052514A1/zh unknown
- 2000-11-16 WO PCT/US2000/031415 patent/WO2001038321A1/en not_active Ceased
- 2000-11-16 CN CNB008160945A patent/CN1185225C/zh not_active Expired - Lifetime
- 2000-11-16 PL PL355607A patent/PL202805B1/pl unknown
- 2000-11-16 DE DE60008136T patent/DE60008136T2/de not_active Expired - Lifetime
- 2000-11-16 AT AT00978699T patent/ATE258927T1/de active
- 2000-11-16 ES ES00978699T patent/ES2216992T3/es not_active Expired - Lifetime
- 2000-11-16 US US09/713,308 patent/US6372920B1/en not_active Expired - Lifetime
- 2000-11-16 EP EP00978699A patent/EP1232152B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2392563C (en)	2011-02-15
HK1049156A1 (en)	2003-05-02
ATE258927T1 (de)	2004-02-15
CN1185225C (zh)	2005-01-19
PL202805B1 (pl)	2009-07-31
DE60008136D1 (de)	2004-03-11
AR026505A1 (es)	2003-02-12
PT1232152E (pt)	2004-06-30
WO2001038321A1 (en)	2001-05-31
CA2392563A1 (en)	2001-05-31
TR200400401T4 (tr)	2004-03-22
HK1049156B (en)	2004-12-10
EP1232152A1 (en)	2002-08-21
HK1052514A1 (zh)	2003-09-19
CN1391569A (zh)	2003-01-15
DK1232152T3 (da)	2004-04-05
US6372920B1 (en)	2002-04-16
DE60008136T2 (de)	2004-09-09
EP1232152B1 (en)	2004-02-04
AU1613101A (en)	2001-06-04
ES2216992T3 (es)	2004-11-01

Publication	Publication Date	Title
PL355607A1 (pl)	2004-05-04	Ulepszony sposób otrzymywania aminotetralin podstawionych azotem
GB9914209D0 (en)	1999-08-18	Process
GB9920917D0 (en)	1999-11-10	Novel process
GB9924882D0 (en)	1999-12-22	Novel process
HUP0103002A3 (en)	2002-09-30	New process for obtaining 17betha-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids
GB9914583D0 (en)	1999-08-25	Novel process
HUP0000559A3 (en)	2003-02-28	Process for preparing cyanoaceticacidesters
GB9926908D0 (en)	2000-01-12	Novel process
GB9916392D0 (en)	1999-09-15	Novel process
GB9930577D0 (en)	2000-02-16	Novel process
GB9914600D0 (en)	1999-08-25	Novel,process
GB9905418D0 (en)	1999-05-05	Process
GB9920147D0 (en)	1999-10-27	Novel process
GB9916187D0 (en)	1999-09-08	Novel process
GB9903087D0 (en)	1999-03-31	Process
GB9920146D0 (en)	1999-10-27	Novel process
GB9919001D0 (en)	1999-10-13	Novel process
GB9915303D0 (en)	1999-09-01	Novel process
GB9921243D0 (en)	1999-11-10	Novel process
GB9923539D0 (en)	1999-12-08	Novel process
HUP0300259A3 (en)	2005-12-28	Process for preparing 5'-acetylstavudine
GB9909973D0 (en)	1999-06-30	Process
GB9920937D0 (en)	1999-11-10	Process
IL146045A0 (en)	2002-07-25	New process
SI1237838T1 (en)	2004-08-31	New process